Talk:Olanzapine: Difference between revisions
→Controversy: new section |
DannyHaszard (talk | contribs) |
||
Line 24: | Line 24: | ||
:what purpose would that serve? <span style="font-size: smaller;" class="autosigned">— Preceding [[Wikipedia:Signatures|unsigned]] comment added by [[Special:Contributions/82.45.216.153|82.45.216.153]] ([[User talk:82.45.216.153|talk]]) 00:34, 15 January 2013 (UTC)</span><!-- Template:Unsigned IP --> <!--Autosigned by SineBot--> |
:what purpose would that serve? <span style="font-size: smaller;" class="autosigned">— Preceding [[Wikipedia:Signatures|unsigned]] comment added by [[Special:Contributions/82.45.216.153|82.45.216.153]] ([[User talk:82.45.216.153|talk]]) 00:34, 15 January 2013 (UTC)</span><!-- Template:Unsigned IP --> <!--Autosigned by SineBot--> |
||
== "Illegal promotion" paragraph removed == |
|||
I've removed the paragraph below. I have no opinion on the drug or its use, or knowledge of the "qui tam" (class action) suits alleged, but it lacks clarity, citations, context, and doesn't make much sense. Please restore the paragraph if you have better sources and wording. [[Special:Contributions/201.171.122.70|201.171.122.70]] ([[User talk:201.171.122.70|talk]]) 09:13, 25 January 2013 (UTC) |
|||
:===(removed paragraph) Illegal promotion in US=== |
|||
:The criminal information alleged that Zyprexa was promoted (1999-2003) in nursing homes and assisted-living facilities for the treatment of disorders such as dementia, Alzheimer’s dementia, depression, anxiety, and sleep problems, and behavioral symptoms such as agitation, aggression, and hostility. The ''[[qui tam]]'' lawsuits alleged that Zyprexa was promoted (1999-2005) for use in patients of all ages and for the treatment of anxiety, irritability, depression, nausea, Alzheimer’s and other mood disorders. Off-label promotion of pharmaceutical drugs is considered, by the U.S. [[Food and Drug Administration]] (FDA), to be a serious crime that undermines their role in drug regulation and public safety.<ref name = "Off-label" /> |
:The criminal information alleged that Zyprexa was promoted (1999-2003) in nursing homes and assisted-living facilities for the treatment of disorders such as dementia, Alzheimer’s dementia, depression, anxiety, and sleep problems, and behavioral symptoms such as agitation, aggression, and hostility. The ''[[qui tam]]'' lawsuits alleged that Zyprexa was promoted (1999-2005) for use in patients of all ages and for the treatment of anxiety, irritability, depression, nausea, Alzheimer’s and other mood disorders. Off-label promotion of pharmaceutical drugs is considered, by the U.S. [[Food and Drug Administration]] (FDA), to be a serious crime that undermines their role in drug regulation and public safety.<ref name = "Off-label" /> |
||
Remember the Zyprexa scandal. |
|||
The Eli Lilly company made an astounding $70 BILLION on Zyprexa that they PUSHED on the elderly and underage children (*Viva Zyprexa* Lilly sales rep slogan) with wanton disregard for the side effects |
|||
*FIVE at FIVE* |
|||
The Zyprexa antipsychotic drug,whose side effects can include weight gain and diabetes, was sold to Veterans,children in foster care, elderly in nursing homes. |
|||
*Five at Five* was the Zyprexa sales rep slogan, meaning *5mg dispensed at 5pm would keep patients quiet*. |
|||
*Tell the truth don't be afraid*. |
|||
-- Daniel Haszard |
|||
FMI http://www.zyprexa-victims.com |
|||
== Controversy == |
== Controversy == |
Revision as of 06:03, 20 April 2013
Pharmacology B‑class High‑importance | ||||||||||
|
Medicine B‑class High‑importance | ||||||||||
|
/Archive 1 |
This page has archives. Sections older than 31 days may be automatically archived by Lowercase sigmabot III when more than 4 sections are present. |
Untitled
Here's an important article that just came out in the NY Times http://www.nytimes.com/2006/12/18/business/18drug.html?hp&ex=1166504400&en=abbfa89f1f363c93&ei=5094&partner=homepage — Preceding unsigned comment added by 71.206.230.233 (talk)
The Chemistry Section
Someone needs to explain in great detail using descriptive words to explain how this chemical is made or synthesized in language that the lay person can understand. A chart is not enough and the section alludes that there are many methods to synthesis this molecule so therefore all methods should be explained. 2602:306:C518:62C0:5C06:758E:E477:60D6 (talk) 23:18, 31 July 2012 (UTC)
- what purpose would that serve? — Preceding unsigned comment added by 82.45.216.153 (talk) 00:34, 15 January 2013 (UTC)
- The criminal information alleged that Zyprexa was promoted (1999-2003) in nursing homes and assisted-living facilities for the treatment of disorders such as dementia, Alzheimer’s dementia, depression, anxiety, and sleep problems, and behavioral symptoms such as agitation, aggression, and hostility. The qui tam lawsuits alleged that Zyprexa was promoted (1999-2005) for use in patients of all ages and for the treatment of anxiety, irritability, depression, nausea, Alzheimer’s and other mood disorders. Off-label promotion of pharmaceutical drugs is considered, by the U.S. Food and Drug Administration (FDA), to be a serious crime that undermines their role in drug regulation and public safety.[1]
Remember the Zyprexa scandal. The Eli Lilly company made an astounding $70 BILLION on Zyprexa that they PUSHED on the elderly and underage children (*Viva Zyprexa* Lilly sales rep slogan) with wanton disregard for the side effects
- FIVE at FIVE*
The Zyprexa antipsychotic drug,whose side effects can include weight gain and diabetes, was sold to Veterans,children in foster care, elderly in nursing homes. *Five at Five* was the Zyprexa sales rep slogan, meaning *5mg dispensed at 5pm would keep patients quiet*.
- Tell the truth don't be afraid*.
-- Daniel Haszard FMI http://www.zyprexa-victims.com
Controversy
Jimmy Wales will help soon. This medication has serious side effects. --Word2013 (talk) 13:12, 19 April 2013 (UTC)